Skip to main content
Log in

Purification of leukemic blast cells from blood smears using laser microdissection

  • Rapid Communication
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

In treatment of acute myeloid leukemia (AML), prognostic factors, including gene mutation and abnormal gene expression, enable risk stratification of patients. However, in the case of a small proportion of leukemic blast cells, such as AML associated with Down syndrome (AML-DS), it is not possible to examine prognostic factors precisely due to the large proportion of normal cells. Here, we present a novel method for examining prognostic factors by making a smear on a membrane slide glass from a small amount of diagnostic specimen and collecting highly pure leukemic blast cells by laser microdissection (LMD). We verified the effectiveness of this method using 10% KPAM1 cell line suspension and peripheral blood containing 20% blast cells obtained from a patient with transient abnormal myelopoiesis (TAM). After making blood smears, approximately 100 cells were collected and analyzed by direct sequencing. Frameshift mutations (2 bp deletion and 17 bp duplication, respectively) in GATA-1 were detected in each sample, suggesting KPAM1 and TAM blast cells were accurately purified. This novel method enables us to precisely examine prognostic factors in many cases, even in cases with a small proportion of leukemic blast cells or small specimens to preserve.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, et al. Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group. Blood Cancer J. 2014;4:e226.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, et al. EVI1 overexpression is a poor prognostic factor in pediatric patients with mixed lineage leukemia-AF9 rearranged acute myeloid leukemia. Haematologica. 2014;99:e225–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Tokumasu M, Murata C, Shimada A, Ohki K, Hayashi Y, Saito AM, et al. Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial. Leukemia. 2015;29:2438–41.

    Article  CAS  PubMed  Google Scholar 

  5. Matsuo H, Nakamura N, Tomizawa D, Saito AM, Kiyokawa N, Horibe K, et al. CXCR4 overexpression is a poor prognostic factor in pediatric acute myeloid leukemia with low risk: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group. Pediatr Blood Cancer. 2016;63:1394–9.

    Article  CAS  PubMed  Google Scholar 

  6. Espina V, Wulfkuhle JD, Calvert VS, VanMeter A, Zhou W, Coukos G, et al. Laser-capture microdissection. Nat Protoc. 2006;1:586–603.

    Article  CAS  PubMed  Google Scholar 

  7. Yoshioka W, Endo N, Kurashige A, Haijima A, Endo T, Shibata T, et al. Fluorescence laser microdissection reveals a distinct pattern of gene activation in the mouse hippocampal region. Sci Rep. 2012;2:783.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Humerick M, Hanson J, Rodriguez-Canales J, Lubelski D, Rashid OM, Salinas YD, et al. Analysis of transcription factor mRNAs in identified oxytocin and vasopressin magnocellular neurons isolated by laser capture microdissection. PLoS One. 2013;8:e69407.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Toki T, Kanezaki R, Adachi S, Fujino H, Xu G, Sato T, et al. The key role of stem cell factor/KIT signaling in the proliferation of blast cells from Down syndrome-related leukemia. Leukemia. 2009;23:95–103.

    Article  CAS  PubMed  Google Scholar 

  10. Crispino JD. GATA1 in normal and malignant hematopoiesis. Semin Cell Dev Biol. 2005;16:137–47.

    Article  CAS  PubMed  Google Scholar 

  11. Hitzler JK, Cheung J, Li Y, Scherer SW, Zipursky A. GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood. 2003;101:4301–4.

    Article  CAS  PubMed  Google Scholar 

  12. Roy A, Roberts I, Norton A, Vyas P. Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis. Br J Haematol. 2009;147:3–12.

    Article  CAS  PubMed  Google Scholar 

  13. Saida S. Evolution of myeloid leukemia in children with Down syndrome. Int J Hematol. 2016;103:365–72.

    Article  CAS  PubMed  Google Scholar 

  14. Spoo AC, Lübbert M, Wierda WG, Burger JA. CXCR4 is a prognostic marker in acute myelogenous leukemia. Blood. 2007;109:786–91.

    Article  CAS  PubMed  Google Scholar 

  15. Ehlers S, Herbst C, Zimmermann M, Scharn N, Germeshausen M, von Neuhoff N, et al. Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse. J Clin Oncol. 2010;28:2591–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor, and Welfare of Japan (H26-061) and JSPS KAKENHI Grant Number 16K19193.

Author information

Authors and Affiliations

Authors

Contributions

Conceived and designed the experiments: HM, TI, YK, TT, KT, EI, and SA. Performed the experiments and analyzed the data: HM, SS, TT, and KT. Wrote the paper: HM.

Corresponding author

Correspondence to Souichi Adachi.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matsuo, H., Shiga, S., Imai, T. et al. Purification of leukemic blast cells from blood smears using laser microdissection. Int J Hematol 106, 55–59 (2017). https://doi.org/10.1007/s12185-017-2227-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-017-2227-z

Keywords

Navigation